Download PDF
Semin intervent Radiol 2011; 28(3): 273-282
DOI: 10.1055/s-0031-1284453
© Thieme Medical Publishers

Medical and Endoscopic Management of Gastric Varices

Abdullah M. S. Al-Osaimi1 , Stephen H. Caldwell1
  • 1Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia
Further Information

Publication History

Publication Date:
15 August 2011 (online)

Also available at
    Permissions and Reprints

ABSTRACT

In the past 20 years, our understanding of the pathophysiology and management options among patients with gastric varices (GV) has changed significantly. GV are the most common cause of upper gastrointestinal bleeding in patients with portal hypertension after esophageal varices (EV) and generally have more severe bleeding than EV. In the United States, the majority of GV patients have underlying portal hypertension rather than splenic vein thrombosis. The widely used classifications are the Sarin Endoscopic Classification and the Japanese Vascular Classifications. The former is based on the endoscopic appearance and location of the varices, while the Japanese classification is based on the underlying vascular anatomy. In this article, the authors address the current concepts of classification, epidemiology, pathophysiology, and emerging management options of gastric varices. They describe the stepwise approach to patients with gastric varices, including the different available modalities, and the pearls, pitfalls, and stop-gap measures useful in managing patients with gastric variceal bleed.

KEYWORDS

Gastric varices - portal hypertension - liver cirrhosis - BRTO - TIPS - splenorenal shunt - cyanoacrylate

REFERENCES

  • 1 Sarin S K, Kumar A. Gastric varices: profile, classification, and management.  Am J Gastroenterol. 1989;  84 (10) 1244-1249
    PubMedGoogle Scholar
  • 2 Stray N, Jacobsen C D, Rosseland A. Injection sclerotherapy of bleeding oesophageal and gastric varices using a flexible endoscope.  Acta Med Scand. 1982;  211 (1-2) 125-129
    PubMedGoogle Scholar
  • 3 Sarin S K, Lahoti D, Saxena S P, Murthy N S, Makwana U K. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients.  Hepatology. 1992;  16 (6) 1343-1349
    CrossrefPubMedGoogle Scholar
  • 4 Caldwell S H, Hespenheide E E, Greenwald B D, Northup P G, Patrie J T. Enbucrilate for gastric varices: extended experience in 92 patients.  Aliment Pharmacol Ther. 2007;  26 (1) 49-59
    CrossrefPubMedGoogle Scholar
  • 5 Arakawa M, Masuzaki T, Okuda K. Pathology of fundic varices of the stomach and rupture.  J Gastroenterol Hepatol. 2002;  17 (10) 1064-1069
    CrossrefPubMedGoogle Scholar
  • 6 Agarwal A K, Raj Kumar K, Agarwal S, Singh S. Significance of splenic vein thrombosis in chronic pancreatitis.  Am J Surg. 2008;  196 (2) 149-154
    CrossrefPubMedGoogle Scholar
  • 7 Heider T R, Azeem S, Galanko J A, Behrns K E. The natural history of pancreatitis-induced splenic vein thrombosis.  Ann Surg. 2004;  239 (6) 876-880 discussion 880-882
    CrossrefPubMedGoogle Scholar
  • 8 Ryan B M, Stockbrugger R W, Ryan J M. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices.  Gastroenterology. 2004;  126 (4) 1175-1189
    CrossrefPubMedGoogle Scholar
  • 9 Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices.  Gastrointest Endosc. 1986;  32 (4) 264-268
    CrossrefPubMedGoogle Scholar
  • 10 Chey W D, Elta G H. Natural history of gastric varices.  Gastroenterology. 1993;  105 (2) 599-602
    PubMedGoogle Scholar
  • 11 Kim T, Shijo H, Kokawa H et al.. Risk factors for hemorrhage from gastric fundal varices.  Hepatology. 1997;  25 (2) 307-312
    CrossrefPubMedGoogle Scholar
  • 12 Sarin S K. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience.  Gastrointest Endosc. 1997;  46 (1) 8-14
    CrossrefPubMedGoogle Scholar
  • 13 Jutabha R, Jensen D M, Kovacs T OG et al.. Initial results of combination banding and sclerotherapy compared to sclerotherapy alone for bleeding gastric varices.  Gastrointest Endosc. 1998;  47 AB86
    PubMedGoogle Scholar
  • 14 Scapa E. Treating gastrointestinal bleeding with endoscopic hemoclips.  Surg Laparosc Endosc. 1997;  7 (2) 94-96
    CrossrefPubMedGoogle Scholar
  • 15 Kravetz D, Bosch J, Arderiu M, Pilar Pizcueta M, Rodés J. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.  Hepatology. 1989;  9 (6) 808-814
    CrossrefPubMedGoogle Scholar
  • 16 Castañeda B, Morales J, Lionetti R et al.. Effects of blood volume restitution following a portal hypertensive-related bleeding in anesthetized cirrhotic rats.  Hepatology. 2001;  33 (4) 821-825
    CrossrefPubMedGoogle Scholar
  • 17 Villanueva C, Ortiz J, Miñana J et al.. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding.  Gastroenterology. 2001;  121 (1) 110-117
    CrossrefPubMedGoogle Scholar
  • 18 de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.  J Hepatol. 2005;  43 (1) 167-176
    CrossrefPubMedGoogle Scholar
  • 19 Gabriel D A, Li X, Monroe III DMIII, Roberts H R. Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets.  J Thromb Haemost. 2004;  2 (10) 1816-1822
    CrossrefPubMedGoogle Scholar
  • 20 Porte R J, Molenaar I Q, Begliomini B EMSALT Study Group et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study.  Lancet. 2000;  355 (9212) 1303-1309
    CrossrefPubMedGoogle Scholar
  • 21 Westerkamp A C, Lisman T, Porte R J. How to minimize blood loss during liver surgery in patients with cirrhosis.  HPB (Oxford). 2009;  11 (6) 453-458
    CrossrefPubMedGoogle Scholar
  • 22 Youssef W I, Salazar F D, Dasarathy S, Beddow T, Mullen K D. Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study.  Am J Gastroenterol. 2003;  98 (6) 1391-1394
    CrossrefPubMedGoogle Scholar
  • 23 Porte R J, Lisman T, Tripodi A, Caldwell S H, Trotter J F. Coagulation in Liver Disease Study Group . The international normalized ratio (INR) in the MELD score: problems and solutions.  Am J Transplant. 2010;  10 (6) 1349-1353
    CrossrefPubMedGoogle Scholar
  • 24 Trotter J F, Olson J, Lefkowitz J, Smith A D, Arjal R, Kenison J. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory.  Am J Transplant. 2007;  7 (6) 1624-1628
    CrossrefPubMedGoogle Scholar
  • 25 Tripodi A, Primignani M, Chantarangkul V et al.. Thrombin generation in patients with cirrhosis: the role of platelets.  Hepatology. 2006;  44 (2) 440-445
    CrossrefPubMedGoogle Scholar
  • 26 Hou M C, Lin H C, Kuo B I, Lee F Y, Schmidt C M, Lee S D. Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage.  Am J Gastroenterol. 1996;  91 (10) 2103-2109
    PubMedGoogle Scholar
  • 27 Bosch J, Thabut D, Albillos A International Study Group on rFVIIa in UGI Hemorrhage et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial.  Hepatology. 2008;  47 (5) 1604-1614
    CrossrefPubMedGoogle Scholar
  • 28 de Franchis R, Arcidiacono P G, Carpinelli L et al.. Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club.  Hepatology. 1993;  18 (5) 1102-1107
    CrossrefPubMedGoogle Scholar
  • 29 Sanyal A J, Freedman A M, Luketic V A et al.. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial.  Ann Intern Med. 1997;  126 (11) 849-857
    PubMedGoogle Scholar
  • 30 Barange K, Péron J M, Imani K et al.. Transjugular intrahepatic portosystemic shunt in the treatment of refractory bleeding from ruptured gastric varices.  Hepatology. 1999;  30 (5) 1139-1143
    CrossrefPubMedGoogle Scholar
  • 31 Tripathi D, Therapondos G, Jackson E, Redhead D N, Hayes P C. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations.  Gut. 2002;  51 (2) 270-274
    CrossrefPubMedGoogle Scholar
  • 32 Henderson J M, Boyer T D, Kutner M H DIVERT Study Group et al. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.  Gastroenterology. 2006;  130 (6) 1643-1651
    CrossrefPubMedGoogle Scholar
  • 33 Ferral H, Gamboa P, Postoak D W et al.. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.  Radiology. 2004;  231 (1) 231-236
    CrossrefPubMedGoogle Scholar
  • 34 Soehendra N, Grimm H, Nam V C, Berger B. N-butyl-2-cyanoacrylate: a supplement to endoscopic sclerotherapy.  Endoscopy. 1987;  19 (6) 221-224
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Rengstorff D S, Binmoeller K F. A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans.  Gastrointest Endosc. 2004;  59 (4) 553-558
    CrossrefPubMedGoogle Scholar
  • 36 Tan P C, Hou M C, Lin H C et al.. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation.  Hepatology. 2006;  43 (4) 690-697
    CrossrefPubMedGoogle Scholar
  • 37 Lo G H, Lai K H, Cheng J S, Chen M H, Chiang H T. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices.  Hepatology. 2001;  33 (5) 1060-1064
    CrossrefPubMedGoogle Scholar
  • 38 Mahadeva S, Bellamy M C, Kessel D, Davies M H, Millson C E. Cost-effectiveness of N-butyl-2-cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding.  Am J Gastroenterol. 2003;  98 (12) 2688-2693
    CrossrefPubMedGoogle Scholar
  • 39 Greenwald B D, Caldwell S H, Hespenheide E E et al.. N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis.  Am J Gastroenterol. 2003;  98 (9) 1982-1988
    CrossrefPubMedGoogle Scholar
  • 40 Procaccini N J, Al-Osaimi A M, Northup P, Argo C, Caldwell S H. Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding: a single-center U.S. analysis.  Gastrointest Endosc. 2009;  70 (5) 881-887
    CrossrefPubMedGoogle Scholar
  • 41 Lo G H, Liang H L, Chen W C et al.. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding.  Endoscopy. 2007;  39 (8) 679-685
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Williams S G, Peters R A, Westaby D. Thrombin—an effective treatment for gastric variceal haemorrhage.  Gut. 1994;  35 (9) 1287-1289
    CrossrefPubMedGoogle Scholar
  • 43 Przemioslo R T, McNair A, Williams R. Thrombin is effective in arresting bleeding from gastric variceal hemorrhage.  Dig Dis Sci. 1999;  44 (4) 778-781
    CrossrefPubMedGoogle Scholar
  • 44 Yang W L, Tripathi D, Therapondos G, Todd A, Hayes P C. Endoscopic use of human thrombin in bleeding gastric varices.  Am J Gastroenterol. 2002;  97 (6) 1381-1385
    CrossrefPubMedGoogle Scholar
  • 45 Ramesh J, Limdi J K, Sharma V, Makin A J. The use of thrombin injections in the management of bleeding gastric varices: a single-center experience.  Gastrointest Endosc. 2008;  68 (5) 877-882
    CrossrefPubMedGoogle Scholar
  • 46 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.  J Gastroenterol Hepatol. 1996;  11 (1) 51-58
    CrossrefPubMedGoogle Scholar
  • 47 Matsumoto A, Hamamoto N, Nomura T et al.. Balloon-occluded retrograde transvenous obliteration of high risk gastric fundal varices.  Am J Gastroenterol. 1999;  94 (3) 643-649
    CrossrefPubMedGoogle Scholar
  • 48 Tanihata H, Minamiguchi H, Sato M et al.. Changes in portal systemic pressure gradient after balloon-occluded retrograde transvenous obliteration of gastric varices and aggravation of esophageal varices.  Cardiovasc Intervent Radiol. 2009;  32 (6) 1209-1216
    CrossrefPubMedGoogle Scholar
  • 49 Cho S K, Shin S W, Do Y S et al.. Development of thrombus in the major systemic and portal veins after balloon-occluded retrograde transvenous obliteration for treating gastric variceal bleeding: its frequency and outcome evaluation with CT.  J Vasc Interv Radiol. 2008;  19 (4) 529-538
    CrossrefPubMedGoogle Scholar
  • 50 Cho S K, Shin S W, Yoo E Y et al.. The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation.  Korean J Radiol. 2007;  8 (6) 520-530
    CrossrefPubMedGoogle Scholar
  • 51 Sabri S S, Swee W, Turba U C et al.. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam.  J Vasc Interv Radiol. 2011;  22 (3) 309-316 quiz 316
    CrossrefPubMedGoogle Scholar
  • 52 Sarin S K, Mishra S R. Endoscopic therapy for gastric varices.  Clin Liver Dis. 2010;  14 (2) 263-279
    CrossrefPubMedGoogle Scholar
  • 53 Irani S, Kowdley K, Kozarek R. Gastric varices: an updated review of management.  J Clin Gastroenterol. 2011;  45 (2) 133-148
    CrossrefPubMedGoogle Scholar
  • 54 Sakurabayashi S, Sezai S, Yamamoto Y, Hirano M, Oka H. Embolization of portal-systemic shunts in cirrhotic patients with chronic recurrent hepatic encephalopathy.  Cardiovasc Intervent Radiol. 1997;  20 (2) 120-124
    CrossrefPubMedGoogle Scholar
  • 55 Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.  J Vasc Interv Radiol. 2001;  12 (3) 327-336
    CrossrefPubMedGoogle Scholar

Abdullah M. S. Al-OsaimiM.D. F.A.C.P. F.A.C.G. A.G.A.F. 

Associate Professor of Medicine and Surgery, Medical Director of Liver Transplantation, Division of Gastroenterology and Hepatology, Deparment of Medicine, University of Virginia Health System

P.O. Box 800708, Charlottesville, VA 22908-0708

Email: aa6h@virginia.edu

      >